Your browser doesn't support javascript.
loading
Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents.
Hao, Chao; Cao, Meng; Ouyang, Hanyi; Chen, Zhuo; Hu, Gaoyun; Li, Qianbin.
Affiliation
  • Hao C; Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
  • Cao M; Hunan Key Laboratory of Small Molecules for Diagnosis & Treatment of Chronic Disease, Changsha, Hunan, 410013, China.
  • Ouyang H; Hunan Key Laboratory of Organ Fibrosis, Changsha, Hunan, 410013, China.
  • Chen Z; Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
  • Hu G; Hunan Key Laboratory of Small Molecules for Diagnosis & Treatment of Chronic Disease, Changsha, Hunan, 410013, China.
  • Li Q; Hunan Key Laboratory of Organ Fibrosis, Changsha, Hunan, 410013, China.
Future Med Chem ; 15(5): 453-465, 2023 03.
Article in En | MEDLINE | ID: mdl-37013895
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carrier Proteins / Protein Serine-Threonine Kinases / Renal Insufficiency, Chronic Limits: Humans Language: En Journal: Future Med Chem Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carrier Proteins / Protein Serine-Threonine Kinases / Renal Insufficiency, Chronic Limits: Humans Language: En Journal: Future Med Chem Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom